Scot-tussin Original Sf Multi-symptom
NDC Package 0372-0004-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Scot-tussin Original Sf Multi-symptom is do not use more than directed - see Liver warning. Marketed by Scot-tussin Pharmacal Co., Inc., this product is identified by NDC 0372-0004 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
0372-0004-04
Package Description
118 mL in 1 BOTTLE
Product Code
0372-0004
11-Digit Billing Format
00372000404
RxNorm Crosswalk
  • RxCUI: 1367384 - acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG in 5 mL Oral Solution
  • RxCUI: 1367384 - acetaminophen 32 MG/ML / pheniramine maleate 0.8 MG/ML / phenylephrine hydrochloride 0.8 MG/ML Oral Solution
  • RxCUI: 1367384 - acetaminophen 160 MG / pheniramine maleate 4 MG / phenylephrine HCl 4 MG per 5 ML Oral Solution
  • RxCUI: 1367384 - APAP 32 MG/ML / Pheniramine Maleate 0.8 MG/ML / Phenylephrine Hydrochloride 0.8 MG/ML Oral Solution

Clinical Specifications

Proprietary Name
Scot-tussin Original Sf Multi-symptom
Dosage Form
-
Usage Information
Do not use more than directed - see Liver warning. follow Dosage Chart. do not take more than 4 doses in any 24-hour period. this product is not intended for use in children under 12 years of age.agedoseAdults and childrenover 12 years old2 teaspoons(2 tsp. 10ml.)every 6 hoursChildren under 12 years oldDO NOT USE

Regulatory & Marketing

Labeler Name
Scot-tussin Pharmacal Co., Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
12-01-1956
Listing Expiration
12-31-2019
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0372-0004-04 identifies a specific commercial package of 118 ml in 1 bottle of Scot-tussin Original Sf Multi-symptom, labeled by Scot-tussin Pharmacal Co., Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Scot-tussin Pharmacal Co., Inc. on December 01, 1956. The current certification is valid through December 31, 2019.

How is this Scot-tussin Pharmacal Co., Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00372000404. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0372-0004-04
11-Digit CMS (5-4-2)
00372-0004-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.